These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 21912808)
1. Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients. Ehrenreich H; Kästner A; Weissenborn K; Streeter J; Sperling S; Wang KK; Worthmann H; Hayes RL; von Ahsen N; Kastrup A; Jeromin A; Herrmann M Mol Med; 2011; 17(11-12):1306-10. PubMed ID: 21912808 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Ehrenreich H; Weissenborn K; Prange H; Schneider D; Weimar C; Wartenberg K; Schellinger PD; Bohn M; Becker H; Wegrzyn M; Jähnig P; Herrmann M; Knauth M; Bähr M; Heide W; Wagner A; Schwab S; Reichmann H; Schwendemann G; Dengler R; Kastrup A; Bartels C; Stroke; 2009 Dec; 40(12):e647-56. PubMed ID: 19834012 [TBL] [Abstract][Full Text] [Related]
3. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial. Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937 [TBL] [Abstract][Full Text] [Related]
4. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage. Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120 [TBL] [Abstract][Full Text] [Related]
5. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner. Thériault P; Le Béhot A; ElAli A; Rivest S Oncotarget; 2016 Jun; 7(24):35552-35561. PubMed ID: 27248662 [TBL] [Abstract][Full Text] [Related]
6. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Herrmann M; Ehrenreich H Restor Neurol Neurosci; 2003; 21(3-4):177-90. PubMed ID: 14530580 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy. Bramlett HM; Dietrich WD; Dixon CE; Shear DA; Schmid KE; Mondello S; Wang KK; Hayes RL; Povlishock JT; Tortella FC; Kochanek PM J Neurotrauma; 2016 Mar; 33(6):538-52. PubMed ID: 26670694 [TBL] [Abstract][Full Text] [Related]
8. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. Villa P; van Beek J; Larsen AK; Gerwien J; Christensen S; Cerami A; Brines M; Leist M; Ghezzi P; Torup L J Cereb Blood Flow Metab; 2007 Mar; 27(3):552-63. PubMed ID: 16835629 [TBL] [Abstract][Full Text] [Related]
9. Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial. Hellewell SC; Mondello S; Conquest A; Shaw G; Madorsky I; Deng JV; Little L; Kobeissy F; Bye N; Bellomo R; Cooper DJ; Vallance S; Board J; Morganti-Kossmann MC Crit Care Med; 2018 Apr; 46(4):554-561. PubMed ID: 29278529 [TBL] [Abstract][Full Text] [Related]
10. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside. Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348 [TBL] [Abstract][Full Text] [Related]
11. Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients (REGENESIS-LED trial). Cramer SC; Hill MD; Int J Stroke; 2014 Apr; 9(3):321-7. PubMed ID: 24588854 [TBL] [Abstract][Full Text] [Related]
12. A systematic review and meta-analysis of erythropoietin in experimental stroke. Jerndal M; Forsberg K; Sena ES; Macleod MR; O'Collins VE; Linden T; Nilsson M; Howells DW J Cereb Blood Flow Metab; 2010 May; 30(5):961-8. PubMed ID: 20040929 [TBL] [Abstract][Full Text] [Related]
13. Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke. Worthmann H; Martens-Lobenhoffer J; Joumaah M; Li N; Lichtinghagen R; Hecker H; Kielstein JT; Ehrenreich H; Bode-Böger SM; Weissenborn K Stroke; 2013 Aug; 44(8):2128-33. PubMed ID: 23788583 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin delivered via intra-arterial infusion reduces endoplasmic reticulum stress in brain microvessels of rats following cerebral ischemia and reperfusion. Zhao H; Wang R; Wu X; Liang J; Qi Z; Liu X; Min L; Ji X; Luo Y J Neuroimmune Pharmacol; 2015 Mar; 10(1):153-61. PubMed ID: 25626440 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681 [TBL] [Abstract][Full Text] [Related]
16. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury. Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518 [TBL] [Abstract][Full Text] [Related]
17. Effects of epoetin alfa on the central nervous system. Cerami A; Brines ML; Ghezzi P; Cerami CJ Semin Oncol; 2001 Apr; 28(2 Suppl 8):66-70. PubMed ID: 11395856 [TBL] [Abstract][Full Text] [Related]
18. The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans. Garcia-Rodriguez JC; Sosa-Teste I ScientificWorldJournal; 2009 Sep; 9():970-81. PubMed ID: 19768354 [TBL] [Abstract][Full Text] [Related]